Modelling mutational landscapes of human cancers in vitro.

Autor:	Olivier M; Molecular Mechanisms and Biomarkers Group, International Agency for Research on Cancer, 69008 Lyon, France., Weninger A; German Cancer Research Center (Deutsches Krebsforschungszentrum), D69120 Heidelberg, Germany., Ardin M; Molecular Mechanisms and Biomarkers Group, International Agency for Research on Cancer, 69008 Lyon, France., Huskova H; Molecular Mechanisms and Biomarkers Group, International Agency for Research on Cancer, 69008 Lyon, France., Castells X; Molecular Mechanisms and Biomarkers Group, International Agency for Research on Cancer, 69008 Lyon, France., Vallée MP; Genetic Cancer Susceptibility Group, International Agency for Research on Cancer, 69008 Lyon, France., McKay J; Genetic Cancer Susceptibility Group, International Agency for Research on Cancer, 69008 Lyon, France., Nedelko T; German Cancer Research Center (Deutsches Krebsforschungszentrum), D69120 Heidelberg, Germany., Muehlbauer KR; German Cancer Research Center (Deutsches Krebsforschungszentrum), D69120 Heidelberg, Germany., Marusawa H; Department of Gastroenterology and Hepatology, Graduate School of Medicine, Kyoto University, Kyoto 606-8507, Japan., Alexander J; Faculty of Medicine and Health, University of Leeds, Leeds LS2 9JT, United Kingdom., Hazelwood L; Faculty of Medicine and Health, University of Leeds, Leeds LS2 9JT, United Kingdom., Byrnes G; Biostatistics Group, International Agency for Research on Cancer, 69008 Lyon, France., Hollstein M; 1] German Cancer Research Center (Deutsches Krebsforschungszentrum), D69120 Heidelberg, Germany [2] Faculty of Medicine and Health, University of Leeds, Leeds LS2 9JT, United Kingdom., Zavadil J; Molecular Mechanisms and Biomarkers Group, International Agency for Research on Cancer, 69008 Lyon, France.
Jazyk:	angličtina
Zdroj:	Scientific reports [Sci Rep] 2014 Mar 27; Vol. 4, pp. 4482. Date of Electronic Publication: 2014 Mar 27.
DOI:	10.1038/srep04482
Abstrakt:	Experimental models that recapitulate mutational landscapes of human cancers are needed to decipher the rapidly expanding data on human somatic mutations. We demonstrate that mutation patterns in immortalised cell lines derived from primary murine embryonic fibroblasts (MEFs) exposed in vitro to carcinogens recapitulate key features of mutational signatures observed in human cancers. In experiments with several cancer-causing agents we obtained high genome-wide concordance between human tumour mutation data and in vitro data with respect to predominant substitution types, strand bias and sequence context. Moreover, we found signature mutations in well-studied human cancer driver genes. To explore endogenous mutagenesis, we used MEFs ectopically expressing activation-induced cytidine deaminase (AID) and observed an excess of AID signature mutations in immortalised cell lines compared to their non-transgenic counterparts. MEF immortalisation is thus a simple and powerful strategy for modelling cancer mutation landscapes that facilitates the interpretation of human tumour genome-wide sequencing data.
Databáze:	MEDLINE
Externí odkaz:	Zobrazit plný text záznamu Plný text ve formátu PDF